2024 NCI CIRP Annual Hybrid Meeting Call for Posters

35 views
Skip to first unread message

The Cancer Imaging Program

unread,
Feb 14, 2024, 10:05:23 AM2/14/24
to tcia-anno...@googlegroups.com
White NCI logo bannerDCTD CIP Template

2024 Co-Clinical Imaging Research Resource Program (CIRP) Annual Hybrid Meeting

Date: May 20-21, 2024

Location: In-person attendance at NCI Shady Grove Campus or Virtual attendance via WebEx

Event and Registration Website: https://events.cancer.gov/cip/cirp

This meeting will focus on how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers, what co-clinical quantitative imaging information is currently available at NCI co-clinical imaging research resources and applications of co-clinical imaging to oncology precision medicine.

The CIRP network was formed in 2018 based on a trans-NCI initiative, with a joint effort of the Cancer Imaging Program at the Division of Cancer Treatment and Diagnosis, the Division of Cancer Biology, and the Division of Cancer Prevention. The mission is to advance precision medicine by establishing consensus-based best practices for co-clinical quantitative imaging to enable disease detection, risk stratification, and assessment/prediction of response to therapy. Previous CIRP annual meetings can be found at https://wiki.nci.nih.gov/display/NCICRIP/Previous+Meetings.

Call for posters:

This call for posters is open to all CIRP and non-CIRP affiliated investigators pursuing research within the scientific scope of the CIRP network.  Investigators are invited to present electronic posters on research progress achieved in their laboratory that are relevant to the scientific scope of CIRP network. Examples of topics include, but are not limited to:

  1. The use of Patient-Derived Xenografts (PDXs) and Genetically Engineered Mouse Models (GEMMs) in therapeutic co-clinical trials.
  2. The use of quantitative imaging methods to assess and/or predict response in co-clinical therapeutic trials that employ GEMMS or PDXs in the preclinical arm.
  3. Advances in preclinical quantitative imaging, image acquisition, data processing and analysis, and methodological development.
  4. Informatics tools and methods for preclinical quantitative imaging of cancers.
  5. Integration of cancer -omics, pathology with preclinical and/or clinical quantitative imaging information.
  6. Resources to support co-clinical trial research.

Please send your one-page abstract to NCI program staff, Huiming Zhang, PhD (zhan...@mail.nih.gov), by April 8, 2024. The CIRP Steering Committee will review the submitted abstracts. Authors of accepted abstracts will be notified by email with instructions to prepare (1) Poster Power Pitch slides (2 slides for a 3-minute presentation) and (2) In-person attendees need to prepare a traditional poster (4X6 feet), and instructions to submit the slides by May 10, 2024.

Important Deadline

Meeting registration is closed on May 6, 2024.

Abstracts for posters are due April 8, 2024.

Hotel Room Block Cut-off date is April 28, 2024.

If you are an individual with a disability who needs reasonable accommodations to participate in this event, please contact Elizabeth Pratt at elizabe...@nih.gov at least five business days before the event, so that we can discuss your accommodation request.

Stay Connected with the National Cancer Institute
  Facebook X logo YouTube Instagram LinkedIn  


Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237)

SUBSCRIBER SERVICES:

Manage Subscriptions  |  Help

 

This email was sent to tcia-anno...@googlegroups.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo
Reply all
Reply to author
Forward
0 new messages